ArticleJournal of cancer research and clinical oncology2023

Hepatic artery intervention combined with immune-targeted therapy is superior to sequential therapy in BCLC-C hepatocellular carcinoma.

Hanzhi Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.